Honours - 11 June 2021

Dr David Spooner is a consultant clinical oncologist specialising in cancer diagnosis and management. He has special interests in treatment with chemotherapy and radiotherapy on the breast, brain (central nervous system), musculoskeletal and young people’s tumours.

Dr Spooner has been involved with the RCR in various educational roles and with membership on various committees, culminating in serving as the Warden of Clinical Oncology from 2006 until 2010 (now known as the Medical Director, Education and Training) and Chair of the FRCR (CO2) Examination Board (2010–2014)

Professor Emma Hall

Emma Hall, Professor of Oncology Trials, is Deputy Director of the Cancer Research UK-funded Clinical Trials and Statistics Unit at The Institute of Cancer Research (ICRCTSU). She is a Chartered Statistician with over 20 years’ experience in the design, methodology and analysis of oncology clinical trials. She leads the ICR-CTSU’s portfolio of research in urological and head and neck cancers with focus on the design and analysis of clinical trials evaluating new radiotherapy techniques and treatments.

Chris Lee

Chris Lee studied for a Master's in Radiation Physics at Queen Mary and Westfield University (University of London) in 1988 while working as a Medical Physicist at St. Bartholomew’s Hospital, London where he joined the teaching faculty of the FRCR Part 1 Physics course. In 1992, he moved to Newcastle General Hospital where he continued his active FRCR teaching role. In 1995, he relocated to Clatterbridge Cancer Centre where he is currently the Lead Consultant Clinical Scientist and Radiation Protection Adviser in Specialised Services.

He has introduced a local FRCR teaching course for physics and carries out 1:1 tutorial sessions with oncology registrars. He has been an integral member of the RCR Clinical Oncology Examination Board as a specialist examiner in Physics since 2015.

Sally-Ann Spencer Grey

After a brief stint in local government, Sally-Ann Spencer Grey retrained and worked as a therapeutic radiographer, followed by a move into Higher Education and then education consultancy in palliative and end-of-life care. She is a charity trustee for a charity that supports military veterans (NGVFA), a higher education lecturer in health and social care (University of Hull and the Open University), and a non-executive director in NHS clinical commissioning.

She was a lay member for the RCR for four years for Council, the Oncology Faculty Board and the Joint Collegiate Council for Oncology and loved every single minute of it. She also crafts incessantly!

Professor Frank Gaillard

Associate Professor Frank Gaillard graduated from the University of Melbourne medical school in 1998. He trained as a radiologist at the Royal Melbourne Hospital, where he eventually returned as a consultant neuroradiologist after completing two years of neuroradiology fellowship training. In addition to his work as a neuroradiologist, A/Prof Frank Gaillard has active research interests in neurodegenerative diseases, imaging of central nervous system tumours and computer-aided MRI interpretation.

He is probably best known as the Founder CEO of Radiopaedia.org, the largest collaborative online radiology resource, which forms one of the cornerstones of medical education throughout much of the world, particularly in developing countries.

Dr Ioanna Nixon

Dr Ioanna Nixon is a consultant oncologist in Glasgow with a special interest in soft tissue and bone sarcomas, GIST tumours, head and neck cancers and clinical innovations. She has been the Clinical Lead for the Scottish Sarcoma Network since 2015 and devoted to promoting patient care across Scotland. Dr Nixon has a leading role in research as the NCRI (National Cancer Research Institute) Chair for Head and Neck epidemiology and survivorship subgroup and is also board member of the British Sarcoma Group and Cancer Throat Foundation Trust. She is Vice President for the Hellenic Paediatric and Young Adults Committee aiming at improving health and wellbeing of children, teenagers and young adults in Greece.

Dr Nixon is also a Visiting Professor at Strathclyde University at Business School and an Honorary Clinical Senior Lecturer in Medical School at Glasgow University. Dr Nixon has been awarded a PhD in Radiotherapy, a Masters in Public Health/Epidemiology (MPH) from the University of Liverpool and is trained in quality improvement and safety having graduated from the Scottish Quality and Safety (SQS) Fellowship. She has been awarded for her contribution in patient care with a Faculty of Management and Leadership (FMLM) Fellowship.

Professor Marcel van Herk

Professor Marcel van Herk, active in radiotherapy since 1982, is Chair in Radiotherapy Physics at the University of Manchester. His group improves the accuracy of radiotherapy in all aspects and describes uncertainties and margins, namely in the upcoming On-Target guidance from the Radiotherapy Board. He first developed electronic portal imaging and his later work has been integrated in the Elekta cone-beam CT image guidance system used clinically worldwide.

For the past ten years, he has also held a part-time teaching role as a Professor at the University of Amsterdam working among others at minimising delineation uncertainties resulting, for instance, in the educational contouring system now used by RCR.

Professor Nicholas James

Professor James is Professor of Prostate and Bladder Cancer Research at the Institute of Cancer Research and the Royal Marsden Hospital, London. He was previously Professor of Clinical Oncology in Birmingham up until 2019. He is also an NIHR Senior Investigator and Deputy Dean of the Institute of Cancer Research. His research is focused on prostate and bladder cancer.

Notably, Professor James is the Chief Investigator on the ground-breaking STAMPEDE trial. The trial has shown that big survival gains can be made by using existing treatments in novel settings. Professor James has led a series of trials which have defined chemoradiotherapy as the standard of care for bladder preservation.